One product doesn't mean focus, it means limited target audience. Also every smart investor knows that someone invested in a company is going to pump it and make negative posts about a company they sold to get people to jump aboard a previously bankrupt company who graduated to SKULL & CROSSBONES. Can agree those are in the past, but what is THCZ going to put in the past next, maybe no bid, or grey markets. Nothing is in the past, it is always up front for people to see. Just take a look at the CEO running things here. It is a joke, like many pinks in the OTC. The difference with GRCU is at least the charts scream oversold as compared to THCZ which is overvalued, representing overbought. If it was undervalued, it would see a steady increase and should have already been at .50. The reason it isn't is because THCZ isn't worth more then a penny at this stage in the game.
News 
Market Data 
Discover 
